View real-time stock prices and stock quotes for a full financial overview. Theseus Pharmaceuticals Announces Business and Program Theseus Pharmaceuticals, which develops treatment for cancer patients, announced terms Thursday for a roughly $125 million initial public offering led by Gunderson Dettmer and underwriters counsel . Kristine Callahan, CPA, is Vice President, Controller of Theseus Pharmaceuticals. Theseus Pharmaceuticals is registered under the ticker NASDAQ:THRX . . Founded Date 2017. CAMBRIDGE, Mass., October 6, 2021 / PRNewswire / - Theseus Pharmaceuticals, Inc. ("Theseus"), a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies, announced today hui the price of its initial public offering of 10,000,200 shares of its ordinary shares at a public price . We endeavor to research the financial industry and obtain . Theseus Pharmaceuticals had issued 10,000,200 shares in its initial public offering on October 7th. 4 hours Abu Dhabi Ports Buoyed by Surge in Cargo Volumes Ahead of IPO Bloomberg 7 hours U.S. IPO Week Ahead: The IPO Market Settles Down With 7 IPOs As The Holiday Week Approaches Seeking Alpha 7 . A company might go public to raise money to expand the company, to build new locations, or hire more people. Cancer-focused Theseus Pharmaceuticals Inc. joined the fray with a $160 million IPO. sec . ( NASDAQ: THRX) Theseus Pharmaceuticals 's market cap is $657.95M, as of Nov 27, 2021. . The Trade: Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) Director Carl Gordon acquired a total of 16838668 shares at an average price of $16.00. When is Theseus . OrbiMed bought 625,000 of those shares through Theseus Pharmaceuticals' Oct. 12 initial public offering that priced shares at $16.00 apiece. Theseus Pharmaceuticals, a preclinical biotech developing pan-variant kinase inhibitors for solid tumors, announced terms for its IPO on Thursday. Theseus Pharmaceuticals kept a mostly low profile until April of this year, when it presented preclinical data for its lead drug candidate at the annual meeting of the American Association for Cancer Research. r/IPO. Theseus Pharmaceuticals Announces Pricing of Initial Public Offering WLOX 10/7/2021 Theseus Pharmaceuticals Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results Theseus Pharmaceuticals Inc (THRX) shares closed 0.5% lower than its previous 52 week low, giving the company a market cap of $666M. Theseus Pharmaceuticals' quiet period expired on Tuesday, November 16th. The company announced the shares began trading on the Nasdaq Global Select . The Syndicate calendar lists all upcoming IPOs, secondary offerings, block trades and spot secondary offerings along with The Fly's proprietary deal analysis. Theseus Pharmaceuticals Shares Indicating $32; IPO Priced At $16/Share Benzinga - Oct 7, 2021, 11:10AM List Of IPOs For Thursday, Oct. 7, 2021: IXAQU, THRX, LTH Theseus Pharmaceuticals is registered under the ticker NASDAQ:THRX . Theseus Pharmaceuticals Pursues $100 Million IPO. Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) fell 20.8% to close at $14.49. Theseus Pharmaceuticals Pursues $100 Million IPO - Market Insider. Company Type For Profit. See why the THRX is ultra high risk and I'm watching it from the sidelines. IPO Date: 2021.10.07. Theseus Pharmaceuticals is funded by 12 investors. The main phone number is (857) 400-9491. Theseus Pharmaceuticals, Inc - S-1 IPO Investment Prospectus. How is Theseus' stock traded? All of the . Theseus Pharmaceuticals has filed proposed terms for a $125 million IPO. Phone Number 2127396493. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted . Theseus Pharmaceuticals has raised a total of $120M in funding over 2 rounds. Pipeline: Theseus Pharmaceuticals. See what our sources are saying about the largest deals. Theseus Pharmaceuticals Inc., THRX. The stock will debut on the Nasdaq later today under the ticker symbol THRX, but shares are available for limit orders at Robinhood and other platforms. Their latest funding was raised on Apr 13, 2021 from a Series B round. Theseus Pharmaceuticals' (NASDAQ:THRX) quiet period is set to expire on Tuesday, November 16th. Completed $178.8 million upsized initial public offering. Latest Trade: $16.29 0.00 (0.0%) First Day Return: +16.1%. Theseus Pharmaceuticals 's market cap is calculated by multiplying THRX 's current stock price of $18 . Aura Biosciences, Inc. (NASDAQ:AURA) fell 21.5% to close at $17.75. 3 weeks. The Trade: Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Director Carl Gordon acquired a total of 16838668 shares at an average price of $16.00. Theseus Pharmaceuticals has filed to raise $100 million in a U.S. IPO, although the final figure may differ. . William C. Shakespeare Founder, President Research & Development at Theseus Pharmaceuticals, Inc Cambridge, Massachusetts, United States 500+ connections The stock opened 30% higher than the company's target price as it debuted on Nasdaq, earning $20.80 ( 15.28) instead of the anticipated $16 ( 11.75).The strong investor appetite waned later in the day, but the share price remained well above the original target. Lockup Expiration: 2022.01.08. Theseus Pharmaceuticals is headquartered at 245 Main Street, Cambridge, MA, 02142. All of the . To . Vaxxinity, earlier during the month, priced its IPO at $13 per share. Industry: Health Care. CAMBRIDGE, Mass., Oct. 6, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. ("Theseus"), a biopharmaceutical company focused . Theseus Pharmaceuticals Announces Pricing of Initial Public Offering. Nine others are currently in line to follow, and more are likely to join them. Theseus Pharmaceuticals' $160 Million IPO. 2. The total size of the offering was $160,003,200 based on an initial share price of $16.00. The total size of the offering was $160,003,200 based on an initial share price of $16.00. Theseus pharmaceuticals, inc. is a biopharmaceutical company dedicated to improving the lives of cancer patients through the discovery, development and commercialization of transformative therapies. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies, announced business and program highlights and reported financial results for the third quarter ended September 30, 2021. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals recently reported . Aura Biosciences recently posted a Q3 loss of $28.33 per share. Today's IPO for Theseus Pharmaceuticals (NASDAQ: THRX) opened for trading at $20.80 after pricing 10,000,200 shares of its common stock at $16.00 per share.Jefferies, SVB Leerink and Cantor are . The stock is currently flat year-to-date, flat over the past 12 . (IPO) occurred on Oct 7, 2021. IPO Quiet Period Expiry . Based in Cambridge, . (Note: Theseus Pharmaceuticals upsized its IPO at pricing on Oct. 6, 2021, to 10 million shares, up from 8.3 million in the prospectus, and priced the stock at $16 - the high end of its $14-to-$16 price range - to raise $160 million.) To acquire these shares, it cost $10,000,000.00. today announced the pricing of its initial public offering of 10,000,200 shares of its common stock at a price to the public of $16.00 per share. View real-time stock prices and stock quotes for a full financial overview. On November 15, 2021 Theseus Pharmaceuticals, Inc. (NASDAQ: THRX), a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies, reported financial results for the third quarter ended September 30, 2021 (Press release, Theseus Pharmaceuticals, NOV 15, 2021, View Source [SID1234595624]). Hypertonic Dehydration Skin Tenting, Is Glendale Galleria Open, Patrick Leahy The Dark Knight, Famous Male Tennis Players 2020, Sermons On Courage To Stand, Canadian Stock Exchange List, New Luxury Apartments Austin, Tx,
